SERINC2-PFDN2 Fusion FISH Probe
The SERINC2-PFDN2 Fusion FISH Probe is used to confirm a fusion of the SERINC2 and PFDN2 genes. The fusion of the SERINC2 and PFDN2 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SERINC2-PFDN2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SERINC2-PFDN2-20-AQAQ | 20 (40 μL) | 200 μL |
|
PFDN2 Gene Summary
This gene encodes a member of the prefoldin beta subunit family. The encoded protein is one of six subunits of prefoldin, a molecular chaperone complex that binds and stabilizes newly synthesized polypeptides, thereby allowing them to fold correctly. The complex, consisting of two alpha and four beta subunits, forms a double beta barrel assembly with six protruding coiled-coils. [provided by RefSeq, Jul 2008]
Gene Name: Prefoldin Subunit 2
Chromosome: CHR1: 161070345 -161087866
Locus: 1q23.3
SERINC2 Gene Summary
The Serine Incorporator 2 (SERINC2) gene is located on chr1 :31882411-31907527 at 1p35.2.
Gene Name: Serine Incorporator 2
Chromosome: CHR1: 31882411 -31907527
Locus: 1p35.2
Gene Diseases
The SERINC2 PFDN2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|